1-229431720-C-A
Variant summary
Our verdict is Pathogenic. The variant received 8 ACMG points: 8P and 0B. PM3_StrongPVS1_Strong
This summary comes from the ClinGen Evidence Repository: The variant c.990+1G>T in ACTA1 occurs within the canonical splice donor site (+1) of intron 6. It is predicted to cause skipping of biologically-relevant-exon resulting in an out of frame deletion. However, it is predicted to escape nonsense mediated decay and remove >10% of the protein (PVS1_Strong). The highest minor allele frequency in gnomAD v4.1.0 is 0.00001883 (31/1180028 alleles) in the European (non-Finnish) population (no population codes met). This variant has been reported in trans with a pathogenic variant in two probands with nemaline myopathy (PMID:19562689, LOVD (https://www.dmd.nl/)), and homozygous in one proband with nemaline myopathy (https://helda.helsinki.fi/handle/10138/157180) which meets PM3_Strong. In summary, the variant meets the criteria to be classified as pathogenic for autosomal recessive alpha-actinopathy. ACMG/AMP criteria met, as specified by the ClinGen Congenital Myopathies VCEP: PVS1_Strong, PM3_Strong (ClinGen Congenital Myopathies VCEP specifications version 1; 08/07/2024). LINK:https://erepo.genome.network/evrepo/ui/classification/CA1442746/MONDO:0100084/169
Frequency
Consequence
NM_001100.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- alpha-actinopathyInheritance: AR, AD Classification: DEFINITIVE Submitted by: ClinGen
- congenital myopathy 2a, typical, autosomal dominantInheritance: AR, SD, AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- congenital myopathy with excess of thin filamentsInheritance: SD Classification: DEFINITIVE Submitted by: Illumina
- congenital myopathy 2c, severe infantile, autosomal dominantInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood-onset nemaline myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- congenital fiber-type disproportion myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- intermediate nemaline myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- progressive scapulohumeroperoneal distal myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- typical nemaline myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- rigid spine syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- severe congenital nemaline myopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- zebra body myopathyInheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 8 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ACTA1 | NM_001100.4 | c.990+1G>T | splice_donor_variant, intron_variant | Intron 6 of 6 | ENST00000366684.7 | NP_001091.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ACTA1 | ENST00000366684.7 | c.990+1G>T | splice_donor_variant, intron_variant | Intron 6 of 6 | 1 | NM_001100.4 | ENSP00000355645.3 | |||
| ENSG00000290037 | ENST00000702606.2 | n.355C>A | non_coding_transcript_exon_variant | Exon 1 of 1 | ||||||
| ACTA1 | ENST00000366683.4 | c.990+1G>T | splice_donor_variant, intron_variant | Intron 6 of 6 | 5 | ENSP00000355644.4 | ||||
| ACTA1 | ENST00000684723.1 | c.855+1G>T | splice_donor_variant, intron_variant | Intron 5 of 5 | ENSP00000508084.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152204Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000119 AC: 3AN: 251344 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1461862Hom.: 0 Cov.: 31 AF XY: 0.0000220 AC XY: 16AN XY: 727236 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152204Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74352 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Actin accumulation myopathy Pathogenic:2
This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. -
This sequence change affects a donor splice site in the last intron (intron 6) of the ACTA1 gene. It is expected to disrupt mRNA splicing and likely results in an absent or disrupted protein product. This variant has been reported in an individual affected with severe nemaline myopathy. It was reported to occur in trans with a pathogenic variant (p.Tyr190*) and to be inherited in an autosomal recessive manner (PMID: 19562689). This variant has also been reported in trans with another pathogenic variant (p.Ala146Profs*46) in a second individual affected with nemaline myopathy (http://www.dmd.nl/nmdb). Truncating mutations in ACTA1 are not known to cause autosomal dominant forms of nemaline myopathy (PMID: 12921789, 19562689). Although donor and acceptor splice site variants are typically truncating (PMID: 16199547) and truncating variants in ACTA1 are known to be pathogenic (PMID: 19562689), the pathogenicity of this donor splice site variant in the last intron is not conclusive due to the uncertain impact on mRNA splicing and protein function. Without additional functional and/or genetic data, this variant has been classified as Likely Pathogenic. -
not provided Pathogenic:2
- -
Not observed at significant frequency in large population cohorts (gnomAD); Canonical splice site variant predicted to result in a null allele in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 16199547, 12921789, 25525159, 31589614, 19562689) -
Alpha-actinopathy Pathogenic:1
The variant c.990+1G>T in ACTA1 occurs within the canonical splice donor site (+1) of intron 6. It is predicted to cause skipping of biologically-relevant-exon resulting in an out of frame deletion. However, it is predicted to escape nonsense mediated decay and remove >10% of the protein (PVS1_Strong). The highest minor allele frequency in gnomAD v4.1.0 is 0.00001883 (31/1180028 alleles) in the European (non-Finnish) population (no population codes met). This variant has been reported in trans with a pathogenic variant in two probands with nemaline myopathy (PMID:19562689, LOVD (https://www.dmd.nl/)), and homozygous in one proband with nemaline myopathy (https://helda.helsinki.fi/handle/10138/157180) which meets PM3_Strong. In summary, the variant meets the criteria to be classified as pathogenic for autosomal recessive alpha-actinopathy. ACMG/AMP criteria met, as specified by the ClinGen Congenital Myopathies VCEP: PVS1_Strong, PM3_Strong (ClinGen Congenital Myopathies VCEP specifications version 1; 08/07/2024). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at